C16.1
Malignant neoplasm of fundus of stomach
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the fundus of the stomach, classified under ICD-10 code C16.1, refers to a type of stomach cancer that develops in the upper part of the stomach called the fundus. This form of cancer occurs when abnormal cells grow uncontrollably in the lining tissue, forming a tumor. Over time, these cancerous cells can invade neighboring tissues and spread to other parts of the body. Recognizing the characteristics and symptoms of this disease can aid in early detection and treatment planning.
Causes & Symptoms
Clinical Causes: Chronic inflammation of the stomach lining (gastritis) Helicobacter pylori infection Lifestyle factors such as smoking and excessive alcohol consumption Diet high in smoked, salted, or pickled foods Family history of stomach cancer Previous stomach surgeries or conditions like pernicious anemia Certain genetic mutations and disorders
Key Symptoms: Persistent indigestion or stomach discomfort Unintentional weight loss Persistent nausea or vomiting Feeling full quickly after eating small amounts Difficulty swallowing (dysphagia) Blood in vomit or stools, indicating bleeding Anemia symptoms such as fatigue and weakness Abdominal pain or discomfort, especially in the upper stomach
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examination, and specific diagnostic tests. These may include:
Treatment Protocols: The treatment approach for malignant neoplasm of the fundus of the stomach depends on the stage of the disease, the patient's overall health, and specific tumor characteristics. Common treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is C16.1 a billable ICD-10 code?
Yes, C16.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C16.1?
Clinical documentation must specify the nature of Malignant neoplasm of fundus of stomach and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
